Patient Medication Guide

Overview

• 1.Chlorpromazine	2.Fluphenazine	3.Haloperidol	4.Loxapine	5.Perphenazine
  6.Aripiprazole	7.Asenapine	8.Clozapine	9.Iloperidone	10.Olanzapine
  11.Paliperidone	12.Quetiapine	13.Risperidone	14.Ziprasidone	15.Lurasidone
  16.Brexpiprazole	17.Cariprazine	18.Lumateperone	19.Benztropine	20.Propranolol
  21.Deutetrabenazine	22.Valbenazine

  Title page
• Description of the psychopharmacological medication agent, including brand and generic names, as well as appropriate FDA indication uses
• Any supporting, valid, and reliable research for non-FDA uses
• Drug classification
• The medication mechanism of action
• The medication pharmacokinetics
• The medication pharmacodynamics
• Appropriate dosing, administration route, and any considerations for dosing alterations
• Considerations of use and dosing in specific specialty populations, such as children, adolescents, elderly, pregnant people, those exhibiting suicidal behaviors, etc.
• Definition of half-life, why half-life is important, and the half-life for your assigned medication
• Side effects/adverse reactions potential
• Discuss clinical concerns with EPS and Tardive Dyskinesia
  Note: Be sure to include screening tools that would be utilized.
• Contraindications for use including significant drug to drug interactions
• Overdose considerations
• Diagnostics and labs monitoring comorbidities considerations
• Legal, ethical, and social considerations
• Pertinent patient education considerations
• References page

Support your rationale with a minimum of three (3) academic resources.

Note: While you may use the course text to support your rationale, it will not count toward the resource requirement. You should be utilizing primary and secondary literature.